Cartesian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	219.2	76.91	106.44	4.74
Short-Term Investments	-	-	28.16	-
Cash & Short-Term Investments	219.2	76.91	134.6	4.74
Cash Growth	3088.33%	-42.86%	2742.70%	-
Accounts Receivable	5.81	8.85	9.76	3.13
Other Receivables	-	-	-	0.23
Receivables	5.81	8.85	9.76	3.35
Prepaid Expenses	4.13	4.97	3.49	0.05
Restricted Cash	-	-	0.29	-
Total Current Assets	229.14	90.73	148.14	8.14
Property, Plant & Equipment	23.75	12.18	14.41	1.5
Long-Term Investments	2	2	2	-
Goodwill	48.16	48.16	-	-
Other Intangible Assets	150.6	150.6	-	-
Other Long-Term Assets	1.67	1.38	1.34	0.03
Total Assets	455.32	305.05	165.89	9.67
Accounts Payable	0.52	3.15	0.32	-
Accrued Expenses	9.02	14.73	14.08	0.79
Current Portion of Long-Term Debt	-	-	8.48	-
Current Portion of Leases	2.77	2.17	1.61	0.17
Current Unearned Revenue	-	2.31	0.59	0.12
Other Current Liabilities	9.09	45.85	-	0.19
Total Current Liabilities	21.41	68.21	25.08	1.27
Long-Term Debt	-	-	17.79	-
Long-Term Leases	11.88	8.79	10.06	1.11
Long-Term Unearned Revenue	-	3.54	-	-
Long-Term Deferred Tax Liabilities	15.85	15.85	-	-
Other Long-Term Liabilities	405.43	348.29	19.14	0.35
Total Liabilities	454.56	444.68	72.06	2.72
Common Stock	0	0.02	0.02	-
Additional Paid-In Capital	687.17	179.05	493.31	6.64
Retained Earnings	-681.82	-614.65	-394.94	-19.61
Comprehensive Income & Other	-4.61	-4.6	-4.56	-
Total Common Equity	0.75	-440.18	93.83	-12.97
Shareholders' Equity	0.75	-139.63	93.83	6.95
Total Liabilities & Equity	455.32	305.05	165.89	9.67
Total Debt	14.65	10.96	37.93	1.28
Net Cash (Debt)	204.55	65.96	96.68	3.46
Net Cash Growth	3391.16%	-31.78%	2698.18%	-
Net Cash Per Share	16.70	12.76	19.88	0.91
Filing Date Shares Outstanding	25.41	5.4	-	3.81
Total Common Shares Outstanding	23.9	5.4	-	3.81
Working Capital	207.73	22.52	123.06	6.87
Book Value Per Share	0.03	-81.55	-	-
Tangible Book Value	-198.01	-638.95	93.83	-12.97
Tangible Book Value Per Share	-8.29	-118.38	-	-
Machinery	12.51	7.63	7.34	0.78
Construction In Progress	3.27	0.15	0.6	-
Leasehold Improvements	0.76	0.06	0.06	-

Source: S&P Capital IQ. Standard template. Financial Sources.